Takeda Shares Plunge on Damages Verdict

April 8 (Bloomberg) –- Bloomberg’s David Ingles reports on Takeda Pharmaceuticals shares plunging in Tokyo after the company was ordered to pay $6B in punitive damages after losing it’s first Federal trial over it’s Actos diabetes drug. He speaks to Rishaad Salamat on Bloomberg Television’s “Asia Edge.” (Source: Bloomberg)
Is Virtual Reality the Next Mega-Trend in Tech?
22:40 - Piper Jaffray's Gene Munster and Canaan Partners' Maha Ibrahim discuss the future of virtual reality with Bloomberg Businessweek's Brad Stone on "Bloomberg West." (Source: Bloomberg)
  • Tech, Financials to Be Rediscovered in 2-3 Years: Lee
  • Week in Review: U.S. GDP Shrinks 0.7% in 1Q
  • Humana Soars as Possible Sale Explored